Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Weinstein

Showing results (611-620 of 796) with videos related to

Pageof 80
Sort By:
Journal of the American Academy of Dermatology|January 10, 2021
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatmentsJoel M Gelfand, April W Armstrong, Stacie Bell, et al.
Journal of the American Academy of Dermatology|September 6, 2020
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1Joel M Gelfand, April W Armstrong, Stacie Bell, et al.
American Journal of Epidemiology|June 22, 2010
Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer CancersMark P Purdue, D Michal Freedman, Susan M Gapstur, et al.
Cancer Causes & Control : CCC|April 13, 2010
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohortsLi Jiao, Amy Berrington de Gonzalez, Patricia Hartge, et al.
Blood|January 13, 2026
Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08Jamie E Flerlage, Angela M Feraco, Yiwang Zhou, et al.
JAMA Network Open|May 10, 2022
Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults: A WikiGuidelines Group Consensus StatementBrad Spellberg, Gloria Aggrey, Meghan B Brennan, et al.
American Journal of Epidemiology|June 22, 2010
Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer CancersMarjorie L McCullough, Stephanie J Weinstein, D Michal Freedman, et al.
Journal of the National Cancer Institute|August 28, 2020
Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate CancerBurcu F Darst, Tokhir Dadaev, Ed Saunders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2022
Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort ConsortiumHilary A Robbins, Aida Ferreiro-Iglesias, Tim Waterboer, et al.
American Journal of Epidemiology|June 22, 2010
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer CancersLisa Gallicchio, Kathy J Helzlsouer, Wong-Ho Chow, et al.
Pageof 80

Showing results (611-620 of 796) with videos related to

Sort By:
Pageof 80
Journal of the American Academy of Dermatology|January 10, 2021
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatmentsJoel M Gelfand, April W Armstrong, Stacie Bell, et al.
Journal of the American Academy of Dermatology|September 6, 2020
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1Joel M Gelfand, April W Armstrong, Stacie Bell, et al.
American Journal of Epidemiology|June 22, 2010
Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer CancersMark P Purdue, D Michal Freedman, Susan M Gapstur, et al.
Cancer Causes & Control : CCC|April 13, 2010
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohortsLi Jiao, Amy Berrington de Gonzalez, Patricia Hartge, et al.
Blood|January 13, 2026
Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08Jamie E Flerlage, Angela M Feraco, Yiwang Zhou, et al.
JAMA Network Open|May 10, 2022
Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults: A WikiGuidelines Group Consensus StatementBrad Spellberg, Gloria Aggrey, Meghan B Brennan, et al.
American Journal of Epidemiology|June 22, 2010
Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer CancersMarjorie L McCullough, Stephanie J Weinstein, D Michal Freedman, et al.
Journal of the National Cancer Institute|August 28, 2020
Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate CancerBurcu F Darst, Tokhir Dadaev, Ed Saunders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2022
Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort ConsortiumHilary A Robbins, Aida Ferreiro-Iglesias, Tim Waterboer, et al.
American Journal of Epidemiology|June 22, 2010
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer CancersLisa Gallicchio, Kathy J Helzlsouer, Wong-Ho Chow, et al.
Pageof 80